Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2024-12-13 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
关于2025年度日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement from Shenzhen Huitai Medical Devices Co., Ltd. regarding the expected daily related-party transactions for the fiscal year 2025. It includes extensive information about the nature, amounts, counterparties, and approval procedures of these related-party transactions. The document also mentions that the matter requires shareholder meeting approval and includes opinions from the board, independent directors, and the sponsor institution. There are no financial statements or comprehensive financial performance data typical of annual or interim reports. The document is not a report itself but an announcement about expected related-party transactions and their governance. This fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement about related-party transactions and governance compliance, not a full financial report or other specific filing type.
2024-12-13 Chinese
中信证券股份有限公司关于深圳惠泰医疗器械股份有限公司放弃优先购买权暨关联交易的核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed report from CITIC Securities regarding Shenzhen Huitai Medical Device Co., Ltd.'s decision to waive its preemptive rights in a related-party transaction involving equity transfer. It includes comprehensive information about the transaction, related parties, financial data, board and supervisory approvals, and the sponsor's verification opinion. The document is not a brief announcement but a substantive report on a specific corporate transaction and related-party dealings. It does not fit categories like Annual Report, Earnings Release, or Management Reports. It is focused on a related-party transaction and the waiver of preemptive rights, which is a capital/financing update type of disclosure. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (5913 characters) supports it being a full report rather than a brief announcement or certification.
2024-12-13 Chinese
关于参加2024年度深圳辖区上市公司集体接待日活动的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from Shenzhen Huitai Medical Equipment Co., Ltd. about participating in a 2024 investor interaction event organized by regulatory and stock exchange authorities. It mentions the event date, format, and topics to be discussed, including company performance and governance. The document does not contain any financial statements, detailed financial data, or formal report content. It is an announcement of an upcoming investor presentation or interaction event rather than the presentation itself or a formal report. Given the nature of the content and length (584 characters), it fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about investor relations activities and does not meet criteria for other specific categories like Investor Presentation (IP) or Annual Report (10-K).
2024-12-06 Chinese
关于自愿披露取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (599 characters) from Shenzhen Huitai Medical Devices Co., Ltd. about voluntarily disclosing the acquisition of a medical device registration certificate by its subsidiary. It describes the product details, impact on the company, and risk warnings. There is no financial data, no mention of financial results, no regulatory certifications, or meeting materials. It is an operational update related to product registration, not a financial report or governance document. Given the nature and length, it fits best as a Regulatory Filing (RNS) which is a fallback category for miscellaneous announcements that do not fit other specific categories.
2024-11-22 Chinese
关于召开2024年第三季度业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about the scheduling and details of a 2024 third quarter earnings explanation meeting (业绩说明会) by Shenzhen Huitai Medical Device Co., Ltd. It provides the date, time, location, participation method, and contact information for the meeting. It references the prior release of the 2024 Q3 report but does not contain any financial data or analysis itself. The document is short (1498 characters) and serves as a notice for an upcoming investor presentation or earnings call rather than the report or transcript itself. Therefore, it is best classified as an Investor Presentation (IP) announcement or related to an earnings explanation meeting. Given the detailed description of the meeting and interaction with investors, the classification fits best with Investor Presentation (IP).
2024-11-19 Chinese
关于公司2021年限制性股票激励计划首次授予及预留部分授予A类限制性股票第一个归属期、B类限制性股票第二个归属期第二次归属结果暨股份上市的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shenzhen Huitai Medical Device Co., Ltd. regarding the completion of the registration and listing of restricted stock under its 2021 restricted stock incentive plan. It details the stock grant, vesting periods, number of shares, board and supervisory approvals, and the impact on share capital and earnings per share. The document is a formal announcement about the stock incentive plan's share registration and listing, including details on share issuance and changes in share capital. It does not contain financial statements or detailed financial analysis but rather reports on the completion of share registration and listing related to the stock incentive plan. This fits the category of a Regulatory Filing (RNS) because it is a regulatory announcement about share issuance and stock incentive plan progress, not a full financial report or a capital/financing update per se. It is not a Capital/Financing Update (CAP) because it focuses on stock incentive plan share registration and listing rather than new fundraising or capital structure changes broadly. It is not a Share Issue/Capital Change (SHA) because it is specifically about restricted stock incentive plan share registration and listing, which is typically reported as a regulatory announcement. Therefore, the best classification is Regulatory Filings (RNS).
2024-10-29 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.